Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clear cell sarcoma and selective IgM deficiency: a case report

N J Vogelzang, H Corwin, J L Finlay

    Cancer
    |January 15, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Ten-year survival rates by PSA nadir in patients with metastatic hormone-sensitive prostate cancer: long-term survival analysis from the ECOG-ACRIN 3805 (CHAARTED) trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2025
    Same author

    Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up.

    Annals of oncology : official journal of the European Society for Medical Oncology·2022
    Same author

    Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS).

    BMC cancer·2021
    Same author

    Antitumor activity of ipatasertib combined with chemotherapy: results from a phase Ib study in solid tumors.

    Annals of oncology : official journal of the European Society for Medical Oncology·2020
    Same author

    Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421.

    Cancer treatment and research communications·2019
    Same author

    Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up.

    Annals of oncology : official journal of the European Society for Medical Oncology·2019
    Same journal

    Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States.

    Cancer·2026
    Same journal

    Toward exercise as standard care for older cancer survivors.

    Cancer·2026
    Same journal

    Maintenance therapy in gynecologic malignancies: Current and future state.

    Cancer·2026
    Same journal

    Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

    Cancer·2026
    Same journal

    Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

    Cancer·2026
    Same journal

    EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

    Cancer·2026
    See all related articles

    This study reports a rare clear cell sarcoma in the Achilles tendon co-occurring with a deficiency in immunoglobulin M (IgM). Suppressor cells in the patient

    Area of Science:

    • Oncology
    • Immunology
    • Pathology

    Background:

    • Clear cell sarcoma of tendons and aponeuroses is a rare soft tissue malignancy.
    • Immunoglobulin M (IgM) deficiency is a primary immunodeficiency state.
    • The co-occurrence of these conditions is exceptionally uncommon.

    Observation:

    • A patient presented with clear cell sarcoma originating in the Achilles tendon, with widespread metastases.
    • The patient exhibited a complete absence of serum IgM, normal IgA, and elevated IgG levels.
    • Microscopic examination revealed glycogen-rich clear cells with both melanotic and amelanotic characteristics.

    Findings:

    • Peripheral blood lymphocytes showed a normal percentage of IgM-bearing cells.
    • In vitro studies demonstrated that the patient's mononuclear cells suppressed IgM production in normal lymphocytes.

    Related Experiment Videos

  • This suggests the involvement of suppressor cells in the pathogenesis of the IgM deficiency.

    • Implications:

    • This case highlights a potential link between specific soft tissue sarcomas and immunoglobulin deficiencies.
    • The findings suggest a possible role for aberrant immune regulation, specifically suppressor cell activity, in combined immunodeficiency and sarcoma development.
    • Further research is warranted to explore the immunological underpinnings and potential shared etiological factors.